Showing results (191-200 of 241) with videos related to
Sort By:
Pageof 25
JACC. Case Reports|July 4, 2025
Expanding the Patient Pool for RilonaceptEmma St John, Jessica R Carey, Tanya Wilcox, et al.Journal of the Air & Waste Management Association (1995)|November 30, 2017
Changes in extreme events and the potential impacts on human healthJesse E Bell, Claudia Langford Brown, Kathryn Conlon, et al.Scientific Reports|June 20, 2015
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's miceSong Li, Huayan Hou, Takashi Mori, et al.Journal of Neuroimmunology|October 12, 2016
Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD miceDarrell Sawmiller, Ahsan Habib, Song Li, et al.BMJ Open|July 21, 2012
The evidence underpinning sports performance products: a systematic assessmentCarl Heneghan, Jeremy Howick, Braden O'Neill, et al.Pharmaceutics|April 30, 2021
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in DogsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.Journal of Personality and Social Psychology|December 10, 2019
Forgiveness takes place on an attitudinal continuum from hostility to friendliness: Toward a closer union of forgiveness theory and measurementDaniel E Forster, Joseph Billingsley, V Michelle Russell, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2013
3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancerEliot T McKinley, R Adam Smith, Ping Zhao, et al.Molecular Pharmaceutics|August 25, 2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro AssessmentDeanna M Mudie, Aaron M Stewart, Nishant Biswas, et al.Pageof 25